Literature DB >> 12578859

Cell type-dependent retention and transmission of HIV-1 by DC-SIGN.

Christine Trumpfheller1, Chae Gyu Park, Jennifer Finke, Ralph M Steinman, Angela Granelli-Piperno.   

Abstract

DC-SIGN (CD209) is a C-type lectin expressed by several groups of dendritic cells (DC), including those derived from blood monocytes and DC found beneath genital epithelium. DC-SIGN binds the envelope glycoprotein of HIV-1 and facilitates transmission of infectious virus to permissive CD4(+) T cells. We have compared the capacity of DC-SIGN in different cell types to bind, retain and transmit infectious HIV-1 to T cells. The analyzed cells included monocyte-derived DC, and three different DC-SIGN-expressing transfectants termed THP, 293 and HOS. Our results show that DC-SIGN transfectants were able to bind HIV-1 virions comparably to DC. However, only the THP monocytic cell line shared with DC the capacity to retain for several days virus that was infectious for T cells. In both THP-DC-SIGN transfectants and DC, but not in 293 cells, HIV-1 was localized to intracellular compartments that did not double label for endosomal and lysosomal markers or for DC-SIGN itself. Virus remained detectable in these compartments for at least 2 days. Anti-DC-SIGN antibodies blocked the binding and transmission of HIV-1 in DC-SIGN transfectants, as monitored by PCR for HIV LTR/gag and p24 ELISA. However anti-DC-SIGN antibodies did not block virus binding and transmission to T cells as well in DC as in THP-DC-SIGN transfectants. Thus, the function of DC-SIGN in HIV-1 transmission depends on its cellular context, since only DC and the THP monocyte cell line, but not 293 and HOS, are able to use DC-SIGN to retain HIV-1 in a highly infectious state for several days.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578859     DOI: 10.1093/intimm/dxg030

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  48 in total

Review 1.  Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Authors:  Allison H Bartlett; Pyong Woo Park
Journal:  Expert Rev Mol Med       Date:  2010-02-01       Impact factor: 5.600

2.  West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection.

Authors:  Carl W Davis; Hai-Yen Nguyen; Sheri L Hanna; Melissa D Sánchez; Robert W Doms; Theodore C Pierson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Macropinocytosis and cytoskeleton contribute to dendritic cell-mediated HIV-1 transmission to CD4+ T cells.

Authors:  Jian-Hua Wang; Clive Wells; Li Wu
Journal:  Virology       Date:  2008-09-18       Impact factor: 3.616

Review 4.  The role of human dendritic cells in HIV-1 infection.

Authors:  Zahra Ahmed; Tatsuyoshi Kawamura; Shinji Shimada; Vincent Piguet
Journal:  J Invest Dermatol       Date:  2014-11-19       Impact factor: 8.551

Review 5.  Dendritic-cell interactions with HIV: infection and viral dissemination.

Authors:  Li Wu; Vineet N KewalRamani
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

6.  Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.

Authors:  Irene S Ludwig; Annemarie N Lekkerkerker; Erik Depla; Fons Bosman; René J P Musters; Stany Depraetere; Yvette van Kooyk; Teunis B H Geijtenbeek
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell-mediated HIV transmission.

Authors:  Theresa L Chang; Natalia Teleshova; Aprille Rapista; Maciej Paluch; Robert A Anderson; Donald P Waller; Lourens J D Zaneveld; Angela Granelli-Piperno; Mary E Klotman
Journal:  FEBS Lett       Date:  2007-08-31       Impact factor: 4.124

8.  HIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN).

Authors:  Nancy P Y Chung; Sabine K J Breun; Arman Bashirova; Joerg G Baumann; Thomas D Martin; Jaideep M Karamchandani; Jason W Rausch; Stuart F J Le Grice; Li Wu; Mary Carrington; Vineet N Kewalramani
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

9.  Suppression of HIV-1 Infectivity by Human Glioma Cells.

Authors:  Sheikh Ariful Hoque; Atsushi Tanaka; Salequl Islam; Gias Uddin Ahsan; Atsushi Jinno-Oue; Hiroo Hoshino
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-07       Impact factor: 2.205

Review 10.  HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?

Authors:  Nuria Izquierdo-Useros; Mar Naranjo-Gómez; Itziar Erkizia; Maria Carmen Puertas; Francesc E Borràs; Julià Blanco; Javier Martinez-Picado
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.